Home/Pipeline/Talis One COVID-19 Test

Talis One COVID-19 Test

SARS-CoV-2 Infection

Commercial (EUA)Terminated

Key Facts

Indication

SARS-CoV-2 Infection

Phase

Commercial (EUA)

Status

Terminated

Company

Talis Biomedical

About Talis Biomedical

Talis Biomedical was founded to commercialize the Talis One platform, a compact, cartridge-based molecular diagnostic system designed for decentralized testing. The company achieved a public listing via a SPAC merger in 2021 but faced insurmountable hurdles in scaling manufacturing and adapting to the post-pandemic market, leading to a strategic wind-down. Its current strategy is solely focused on liquidating assets and seeking a sale or merger of its remaining technology and intellectual property.

View full company profile

Therapeutic Areas

Infectious Disease

Other SARS-CoV-2 Infection Drugs

Drug	Company	Phase	Status
Logix Smart COVID-19 Test	Co-Diagnostics	Commercial	Marketed
COV19 qcLAMP Kit	BIOPIX-T	Approved	Commercial (CE-IVD)
GenBody COVID-19 Ag Test	GenBody	Approved	Active
CovidDetect	Prime Discoveries	Commercial	Active
FabenCOV® (e-FabRIC)	Fabentech	Phase 2	Active
Favipiravir	Viriom	Bioequivalence	Active
EDP-323	Enanta Pharmaceuticals	Phase 1	Active
InteliSwab® COVID-19 Rapid Antigen Test	OraSure Technologies	Approved	Commercial